STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT
A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Sponsor: Amicus Therapeutics
Terminated
As a result of change of clinical development plan.
Other terminated trials from Amicus Therapeutics
Other Late-onset Pompe Disease trials with similar outcome
This observational or N/A phase trial investigates Late-onset Pompe Disease and is currently terminated or withdrawn. Amicus Therapeutics leads this study, which shows 15 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Aug 2025 — Present [monthly]
Terminated
-
Sep 2024 — Aug 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 10 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Mar 2019 — Nov 2020 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Oct 2018 — Mar 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Jan 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Amicus Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .